Supreme Court temporarily preserves abortion pill access
The Supreme Court on Friday upheld nationwide access to the abortion pill mifepristone — at least for the time being.
In its first major weigh-in since overturning Roe v. Wade, the court blocked a decision by Texas U.S. District Judge Matthew Kacsmaryk that would have overturned the FDA's approval of the drug. The Supreme Court issued a brief emergency action against Kacsmaryk's ruling, and did not specify why they blocked his decision. However, the case is expected to be litigated for months, and it is likely that the justices upheld the status quo simply to give themselves time to consider their next steps.
The decision by the Supreme Court means that mifepristone will remain on the market for the foreseeable future, and that's a significant victory for the Biden administration, which has fought to codify abortion rights since Roe v. Wade was overturned. The court's ruling means that mifepristone will also remain available by mail, and women can still take it at home up to 10 weeks into a pregnancy, NBC News reported.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
In a statement, President Biden praised the court's decision, saying Kacsmaryk's ruling "undermined the FDA's medical judgment and put women's health at risk."
The Supreme Court has a 6-3 conservative majority, and two conservative justices, Clarence Thomas and Samuel Alito, issued dissenting opinions.
While Thomas did not explain his reasoning, Alito claimed that the public would not have been harmed if the court had allowed Kacsmaryk's ruling to stand. "It would simply restore the circumstances that existed (and that the government defended) from 2000 to 2016 under three presidential administrations," Alito wrote. He added that letting Kacsmaryk's ruling take effect "would not express any view on the merits of the question whether the FDA acted lawfully in any of its actions regarding mifepristone."
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Justin Klawans has worked as a staff writer at The Week since 2022. He began his career covering local news before joining Newsweek as a breaking news reporter, where he wrote about politics, national and global affairs, business, crime, sports, film, television and other news. Justin has also freelanced for outlets including Collider and United Press International.
-
NASA discovered 26 microbes in their cleanroomsUnder the radar The bacteria could contaminate space
-
The elite falcon trade in the Middle EastUnder the Radar Popularity of the birds of prey has been ‘soaring’ despite doubts over the legality of sourcing and concerns for animal welfare
-
A running list of the international figures Donald Trump has pardonedin depth The president has grown bolder in flexing executive clemency powers beyond national borders
-
How robust is the rule of law in the US?TODAY’S BIG QUESTION John Roberts says the Constitution is ‘unshaken,’ but tensions loom at the Supreme Court
-
Hegseth moves to demote Sen. Kelly over videospeed read Retired Navy fighter pilot Mark Kelly appeared in a video reminding military service members that they can ‘refuse illegal orders’
-
Trump says US ‘in charge’ of Venezuela after Maduro grabSpeed Read The American president claims the US will ‘run’ Venezuela for an unspecified amount of time, contradicting a statement from Secretary of State Marco Rubio
-
CBS pulls ‘60 Minutes’ report on Trump deporteesSpeed Read An investigation into the deportations of Venezuelan migrants to El Salvador’s notorious prison was scrapped
-
Trump administration posts sliver of Epstein filesSpeed Read Many of the Justice Department documents were heavily redacted, though new photos of both Donald Trump and Bill Clinton emerged
-
Trump HHS moves to end care for trans youthSpeed Read The administration is making sweeping proposals that would eliminate gender-affirming care for Americans under age 18
-
Jack Smith tells House of ‘proof’ of Trump’s crimesSpeed Read President Donald Trump ‘engaged in a criminal scheme to overturn the results of the 2020 presidential election,’ hoarded classified documents and ‘repeatedly tried to obstruct justice’
-
House GOP revolt forces vote on ACA subsidiesSpeed Read The new health care bill would lower some costs but not extend expiring Affordable Care Act subsidies
